CheckMyRecalls

MACLEODS PHARMA USA, INC recalls Levothyroxine Sodium Tablets USP 150…

MACLEODS PHARMA USA, INC recalls Levothyroxine Sodium Tablets USP 150 mcg

Published
1 Apr 2026
Units affected
1315 bottles
Agency
FDA
Country
United States

The hazard

Subpotent Drug

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44

Brand / company
MACLEODS PHARMA USA, INC
Codes / lots
Lot 16240062A, exp date 3/2026
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 1 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.